Hormone therapy and cardiovascular risk: Biomarkers to enlighten the window hypothesis

Discover the intricate relationship between Hormone Therapy (HT) and cardiovascular risk through the lens of biomarkers in this on-demand webinar presented by expert Antonio Cano.

In this enlightening session, gain valuable insights into the evolving concept of the window hypothesis and its implications for cardiovascular health during menopause. Explore how biomarkers can shed light on the effects of HT on cardiovascular risk, providing a deeper understanding of the timing and duration of therapy.

Stay at the forefront of menopausal health and cardiovascular research. Watch now to enhance your clinical expertise and provide comprehensive care to women considering or undergoing HT, taking into account biomarker insights to optimize cardiovascular health and overall well-being. Empower yourself to make informed decisions in menopause management, utilizing biomarkers to assess and manage cardiovascular risk for improved patient outcomes.